High Dose Favipiravir Countered SARS-CoV-2 in Hamsters, Hydroxychloroquine Ineffective Medical Countermeasures October 10, 2020 …
Remdesivir: Second Mechanism of Action Against SARS-CoV-2 Revealed in New Study Medical Countermeasures September 23, 2020 …
UC Riverside Scientists Use AI to Drive COVID Countermeasure Discovery Medical Countermeasures August 12, 2020 …
Urgent Phase I/II Clinical Trial Funding to Repurpose Existing Therapeutics to Treat COVID-19 Contracts + Grants August 6, 2020 …
Antiviral Remdesivir Prevents Disease Progression in Monkeys with COVID-19 Medical Countermeasures April 17, 2020 …
Ridgeback Receives UK Clearance to Begin Human Testing of Antiviral for COVID-19 Industry News April 14, 2020 …
FDA Approves Ridgeback Biotherapeutics to Begin Human Testing of Potential Treatment for COVID-19 Medical Countermeasures April 7, 2020 …
Why Don’t We Have Drugs to Treat COVID-19 and How Long Will It Take to Develop Them? Medical Countermeasures March 21, 2020 …
Patients in Nebraska Part of First COVID-19 Clinical Trial in U.S. Medical Countermeasures February 25, 2020 …
Columbia University Researchers Awarded $2 Million to Identify Antiviral Drugs for New Coronavirus Medical Countermeasures February 20, 2020 …
J&J to Expand Partnership with HHS to Accelerate Discovery of COVID-19 Therapeutics Medical Countermeasures February 18, 2020 …
Emory, Collaborators Testing Antiviral Drug as Potential Treatment for Coronaviruses Medical Countermeasures February 15, 2020 …
BARDA Seeks Input from Suppliers on Potential SARS-CoV-2 Medical Countermeasures Contracts + Grants February 2, 2020 …
Atriva Therapeutics Reports Results of Phase I Clinical Trial for ATR-002 Antiviral Industry News November 8, 2019 …
AbCellera to Lead Development of Rapid Response Platform Against Pandemic Threats Contracts + Grants March 14, 2018 …
Stopping Pandemic X: DARPA Names Researchers Working to Halt Outbreaks Biodetection February 22, 2018 …
